Exact Mass: 650.0649102000001
Exact Mass Matches: 650.0649102000001
Found 46 metabolites which its exact mass value is equals to given mass value 650.0649102000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Methyl 2,3,6-tri-O-galloyl-beta-D-glucopyranoside
Methyl 2,3,6-tri-O-galloyl-beta-D-glucopyranoside is found in herbs and spices. Methyl 2,3,6-tri-O-galloyl-beta-D-glucopyranoside is isolated from Sanguisorba officinalis (burnet bloodwort). Isolated from Sanguisorba officinalis (burnet bloodwort). Methyl 2,3,6-tri-O-galloyl-beta-D-glucopyranoside is found in tea and herbs and spices.
3,4,5-trihydroxy-2-({3,4,5,11,12,13,22,23-octahydroxy-8,18-dioxo-9,14,17-trioxatetracyclo[17.4.0.0(2),.0(1),(1)]tricosa-1(23),2,4,6,19,21-hexaen-21-yl}oxy)benzoic acid
Methyl 3,4,6-tri-O-galloyl-beta-D-glucopyranoside
Methyl 3,4,6-tri-O-galloyl-beta-D-glucopyranoside is found in herbs and spices. Methyl 3,4,6-tri-O-galloyl-beta-D-glucopyranoside is isolated from underground parts of Sanguisorba officinalis (burnet bloodwort). Isolated from underground parts of Sanguisorba officinalis (burnet bloodwort). Methyl 3,4,6-tri-O-galloyl-beta-D-glucopyranoside is found in tea and herbs and spices.
Bisnorbadioquinone A
Bisnorbadioquinone A is found in mushrooms. Bisnorbadioquinone A is isolated from higher fungus Xerocomus badius (kostanjevka). Isolated from higher fungus Xerocomus badius (kostanjevka). Bisnorbadioquinone A is found in mushrooms.
Bisnorbadioquinone A
Methyl 3,4,6-tri-O-galloyl-b-D-glucopyranoside
Methyl 2,3,6-tri-O-galloyl-b-D-glucopyranoside
(2-hydroxyethyl)dimethyl[3-[(3-sulphopropyl)[(tridecafluorohexyl)sulphonyl]amino]propyl]ammonium hydroxide
1,1-Bis (di-t-butylphosphino)ferrocene palladium dichloride,
C26H44Cl2FeP2Pd (650.0679283999999)
(r)-(+)-5,5-dichloro-6,6-dimethoxy-2,2-bis(diphenylphosphino)-1,1-biphenyl
C38H30Cl2O2P2 (650.1098000000001)
disodium 3-[[4-amino-9,10-dihydro-3-[2-hydroxy-3-(sulphonatooxy)propoxy]-9,10-dioxo-1-anthryl]amino]-2,4,6-trimethylbenzenesulphonate
C26H24N2Na2O11S2 (650.0616874)
3,3-(Biphenyl-4,4-diyldidiazene-2,1-diyl)bis(4-aminonaphthalene-1-sulfonate)
[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-formyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate
PI3K/AKT-IN-2
C32H27BrO10 (650.0787502000001)
PI3K/AKT-IN-2 (Compound 12c) is a PI3K and AKT inhibitor. PI3K/AKT-IN-2 blocks the epithelial-mesenchymal transition (EMT) and induces apoptosis. PI3K/AKT-IN-2 inhibits the polymerization of tubulin[1].
(1s,8r,9s,18r,19s,21r,22s)-7,7,8,12,13,22-hexahydroxy-21-(hydroxymethyl)-3,6,16-trioxo-2,17,20,23-tetraoxapentacyclo[16.3.1.1⁸,¹¹.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,10,12,14-tetraen-19-yl 3,4,5-trihydroxybenzoate
7,8,8,12,13,22-hexahydroxy-21-(hydroxymethyl)-3,6,16-trioxo-2,17,20,23-tetraoxapentacyclo[16.3.1.1⁷,¹¹.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,10,12,14-tetraen-19-yl 3,4,5-trihydroxybenzoate
(1s,7s,9s,18r,19s,21r,22s)-7,8,8,12,13,22-hexahydroxy-21-(hydroxymethyl)-3,6,16-trioxo-2,17,20,23-tetraoxapentacyclo[16.3.1.1⁷,¹¹.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,10,12,14-tetraen-19-yl 3,4,5-trihydroxybenzoate
3-[3,4,5,17,18,19-hexahydroxy-8,14-dioxo-11-(3,4,5-trihydroxybenzoyloxy)-9,13-dioxatricyclo[13.4.0.0²,⁷]nonadeca-1(19),2(7),3,5,15,17-hexaen-10-yl]-2,3-dihydroxypropanoic acid
[4-(8-{5-[carboxy(4-hydroxyphenyl)methylidene]-4-hydroxy-2-oxofuran-3-yl}-5,6-dioxonaphthalen-2-yl)-3-hydroxy-5-oxofuran-2-ylidene](4-hydroxyphenyl)acetic acid
(2r,3r)-3-[(10s,11r)-3,4,5,17,18,19-hexahydroxy-8,14-dioxo-11-(3,4,5-trihydroxybenzoyloxy)-9,13-dioxatricyclo[13.4.0.0²,⁷]nonadeca-1(19),2(7),3,5,15,17-hexaen-10-yl]-2,3-dihydroxypropanoic acid
(1s,8r,9r,18r,19s,21r,22s)-7,7,8,12,13,22-hexahydroxy-21-(hydroxymethyl)-3,6,16-trioxo-2,17,20,23-tetraoxapentacyclo[16.3.1.1⁸,¹¹.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,10,12,14-tetraen-19-yl 3,4,5-trihydroxybenzoate
6,12-bis(6-bromo-1h-indol-3-yl)-11-hydroxy-2,9-diimino-1,3,8-trimethyl-1,3,8,10-tetraazadispiro[4.1.4⁷.1⁵]dodec-10-en-4-one
C27H24Br2N8O2 (650.0388843999999)
[(2e)-4-{7-[(5e)-5-[carboxy(4-hydroxyphenyl)methylidene]-4-hydroxy-2-oxofuran-3-yl]-3,4-dioxonaphthalen-1-yl}-3-hydroxy-5-oxofuran-2-ylidene](4-hydroxyphenyl)acetic acid
7,7,8,12,13,22-hexahydroxy-21-(hydroxymethyl)-3,6,16-trioxo-2,17,20,23-tetraoxapentacyclo[16.3.1.1⁸,¹¹.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,10,12,14-tetraen-19-yl 3,4,5-trihydroxybenzoate
(2r,3r)-3-[(10s,11s)-3,4,5,17,18,19-hexahydroxy-8,14-dioxo-11-(3,4,5-trihydroxybenzoyloxy)-9,13-dioxatricyclo[13.4.0.0²,⁷]nonadeca-1(19),2(7),3,5,15,17-hexaen-10-yl]-2,3-dihydroxypropanoic acid
1,8,17,18,22,22-hexahydroxy-9-(hydroxymethyl)-2,5,14-trioxo-6,10,13,23-tetraoxapentacyclo[17.3.1.0⁴,²¹.0⁷,¹².0¹⁵,²⁰]tricosa-3,15,17,19-tetraen-11-yl 3,4,5-trihydroxybenzoate
(7s,8r,9r,11s,12r,21r)-1,8,17,18,22,22-hexahydroxy-9-(hydroxymethyl)-2,5,14-trioxo-6,10,13,23-tetraoxapentacyclo[17.3.1.0⁴,²¹.0⁷,¹².0¹⁵,²⁰]tricosa-3,15,17,19-tetraen-11-yl 3,4,5-trihydroxybenzoate
[(2r,3r,4s,5r,6r)-3-hydroxy-6-methoxy-4,5-bis(3,4,5-trihydroxybenzoyloxy)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate
(1s,7s,9r,18r,19s,21r,22s)-7,8,8,12,13,22-hexahydroxy-21-(hydroxymethyl)-3,6,16-trioxo-2,17,20,23-tetraoxapentacyclo[16.3.1.1⁷,¹¹.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,10,12,14-tetraen-19-yl 3,4,5-trihydroxybenzoate
(1s,9r,18r,19s,21r,22s)-7,7,8,12,13,22-hexahydroxy-21-(hydroxymethyl)-3,6,16-trioxo-2,17,20,23-tetraoxapentacyclo[16.3.1.1⁸,¹¹.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,10,12,14-tetraen-19-yl 3,4,5-trihydroxybenzoate
(5r,6r,7r,12r)-6,12-bis(6-bromo-1h-indol-3-yl)-11-hydroxy-2,9-diimino-1,3,8-trimethyl-1,3,8,10-tetraazadispiro[4.1.4⁷.1⁵]dodec-10-en-4-one
C27H24Br2N8O2 (650.0388843999999)